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Introduction 
        Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an infectious 
disease that has adversely affected human beings for many centuries. (Lonnroth., K. & 
Raviglione. M,2008). 
        The Japanese Respiratory Society has proposed 6-point scale (0–5) to assess 
the clinical severity of CAP; Age, Dehydration, Respiratory failure, Orientation 
disturbance, and blood Pressure (A-DROP). (Matsushima T,2005). 
The purpose of this retrospective study was to determine whether A-DROP 
could predict the risk of death in patients with pulmonary TB. 
 
Materials and Methods 
 Patients  
The study was a retrospective cohort study of in-patients admitted to 
Yokohama City University Hospital. The patient records were reviewed from April 2007 
to May 2015 on the basis of the admission. All the consecutive patients admitted to the 
isolation wards with a primary diagnosis of pulmonary TB and satisfying the inclusion 
criteria were reviewed.  
The inclusion criteria were as follows: (i) active smear-positive pulmonary TB 
diagnosed with sputum culture and smear, (ii) newly diagnosed disease (patients who 
had already started treatment in another hospital were excluded), (iii) age ≥ 15 years on 
admission, and (iv) admission after TB diagnosis.  
Exclusion criteria were (i) HIV positive status, (ii) MDR-TB, i.e. resistance to 
both isoniazid and rifampicin, (iii) transferred out, i.e. patients moved to another 
facility before the negative infectivity was confirmed, (iv) treatment failure that was 
defined by the persistent smear positivity after 12 months of admission (Laserson, K. F., 
et al,2005).  
We evaluated the patients’ severity at admission using the A-DROP score 
(Shindo, Y., et al,2008). All components of the A-DROP score were clearly described in 
the chart on admission.  
The A-DROP scoring system assesses the following parameters: (i) Age (men ≥ 70 years, 
women ≥ 75 years); (ii) Dehydration (blood urea nitrogen ≥ 21 mg/dL); (iii) Respiratory 
failure (arterial oxygen saturation ≤ 90% or arterial oxygen pressure ≤ 60 mm Hg); (iv) 
Orientation disturbance (confusion); and (v) blood Pressure (systolic blood pressure ≤ 90 
mmHg).( Shindo, Y., et al,2008, The Japanese Respiratory Society, 2005).  
 
Statistics 
Fisher’s exact test and a Mann-Whitney rank sum test were used for binary 
variables and continuous variables, respectively. The receiver operating characteristics 
(ROC) curve and area under the ROC curve (AUC) were used to evaluate the predictive 
ability of the A-DROP score for in-hospital death. A Kaplan-Meier curve and log-rank 
test were used to compare the survival of patients with each A-DROP score. For the 
Kaplan-Meier curve analysis, patients were censored when discharged alive. Univariate 
logistic regression analysis was used to estimate how a one-point increase in the total 
A-DROP score affected in-hospital mortality. Multiple variate logistic regression 
analysis was used to estimate how each component of the A-DROP score affected 
in-hospital mortality. The Cox proportional hazard model was used to calculate the 
hazard ratio (HR). Medians are presented with the interquartile range (IQR). 
All analyses were performed using GraphPad Prism version 6.0 (GraphPad 
Software, San Diego, CA, USA) and Excel Toukei 2012 (SSRI, Tokyo, Japan). 
 
Results 
The cohort consisted of 134 men (38.8%), 211 women (61.2%), 272 who discharged alive 
(28.8%), and 73 who died in-hospital (21.2%) with a median age of 72 (IQR: 54-82) years. 
A one-point increase in the A-DROP score was associated with a higher risk for 
in-hospital mortality with odds ratio of 3.8 (95% confidence interval 2.8-5.2, P<0.001). 
The area under receiver operating characteristics curve was 0.86. The total score cutoff 
of 1.5 provided the best Youden Index of 0.61. Using this criteria, total score > 1.5, 
sensitivity was 85% and specificity was 76%. Kaplan-Meier curve clearly indicated that 
in-hospital mortality increased with higher A-DROP scores (Log-rank test <0.001).  
 
Discussion 
        We retrospectively revealed that the A-DROP score effectively determines 
all-cause in-hospital mortality in HIV-negative non-MDR smear-positive TB. Sensitivity 
analyses based on treatment regimen and different outcome, i.e. in-hospital death and 
28-day death, ensured the robustness of the result. To our knowledge, this is the first 
study that has evaluated the prognostic ability of the A-DROP score for TB cases while 
previous studies evaluated CAP patients. The study results showed that each 
component of the A-DROP score, except for low blood pressure, along with the total 
A-DROP score had good predictive ability for in-hospital mortality for TB patients. We 
think the A-DROP score is useful when physicians treat TB patients for some purposes. 
First, the scoring system let us know which patients needed close monitoring during 
their hospital stay. Second, knowing the poor prognosis, patients, family, and physicians 
can discuss advanced directives concerning the intensive treatment. Some patients, 
especially the elderly, do not like to have intensive care such as mechanical ventilation 
[5,6]. Third, having an accurate prognosis of patients enables physicians to provide 
accurate information to patients. Provision of sufficient information is particularly 
important for admitted smear-positive TB patients because they usually have anxiety 
about the long-term hospitalization (Moussas, G., et al,2008). In conclusion, A-DROP 
score clearly indicate pulmonary tuberculosis in-hospital mortality. 
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